Cargando…
Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...
Autores principales: | Ahmed, Yasar Albushra Abdul Rahiem, Eltayeb, Awad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913129/ https://www.ncbi.nlm.nih.gov/pubmed/24505516 |
Ejemplares similares
-
Clinical challenges: Myeloma and concomitant type 2 diabetes
por: Ali, Mohamed Ahmed, et al.
Publicado: (2013) -
Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test
por: Alqahtani, Naser, et al.
Publicado: (2013) -
Analyzing the Curriculum of the Faculty of Medicine, University of Gezira using Harden’s 10 questions framework
por: AHMED, YASAR ALBUSHRA, et al.
Publicado: (2017) -
The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma
por: Gor, Dhairya, et al.
Publicado: (2022) -
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
por: Yamanouchi, Toshikazu
Publicado: (2010)